DJIA 16,902.10 -10.19 -0.06%
NASDAQ 4,743.64 -47.51 -0.99%
S&P 500 1,991.27 -4.56 -0.23%
market minute promo

13.74 -0.58 (-4.05%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

HALO $13.74 -4.05%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.29
Previous Close $14.32
Daily Range $13.50 - $14.31
52-Week Range $7.51 - $25.25
Market Cap $1.8B
P/E Ratio -46.19
Dividend (Yield) $0.00 (0.0%)
Volume 569,993
Average Daily Volume 1,281,170
Current FY EPS -$0.37




Drug Makers

Halozyme Therapeutics, Inc. (HALO) Description

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets. Website:

News & Commentary

3 Biotechs That Play Well with Others

Kindergarten teachers would be proud -- instead of battling to beat out their competitors, these companies are relying on a cooperative strategy that could benefit everyone involved -- including investors.

Benzinga's Top Initiations

Why Shares of Halozyme Therapeutics Inc. Plunged 24% in August

Mr. Market sends shares lower after the company reports good news. Could this be a buying opportunity?

First Week of October 16th Options Trading For Halozyme Therapeutics (HALO)

Should Your Portfolio Say Hello to Halozyme Therapeutics Inc.?

This small-cap biotech has been crushing the markets for years. Does it deserve a place in your portfolio?

Oversold Conditions For Halozyme Therapeutics (HALO)

Today's Dead Cat Bounce Stock Is Halozyme Therapeutics (HALO)

Market Is Poised To Rally - Cramer's Mad Money (8/12/15)

Jim Cramer Advises His Viewers On Halozyme Therapeutics, CF Industries And Tower International

Why Halozyme Shares Jumped 10% Today

Halozyme's new financial guidance suggests it's in good shape to support its clinical development pipeline.

See More HALO News...

HALO's Top Competitors

HALO $13.74 (-4.05%)
Current stock: HALO
AMGN $147.34 (-0.48%)
Current stock: AMGN
GILD $98.64 (-1.63%)
Current stock: GILD
BIIB $275.19 (-1.45%)
Current stock: BIIB